23 Oct 2001, 13:31 UTC
Morning Market View for October 23, 2001
- From
- Schwab Alerts schwabalerts.marketupdates@schwab.com
- Date
- Tue, 23 Oct 2001 06:31:09 -0700 (PDT)
Charles Schwab & Co., Inc.
Email Alert
Morning Market View(TM)
for Tuesday, October 23, 2001
as of 9:30AM EDT
Information provided by Schwab Center for Investment Research
STOCKS, YANKEES ON A TEAR
Much like the recent winning trend of the world champion New
York Yankees, stocks were poised to add to recent gains at the
open as earnings season continues in full swing amid the
backdrop of an ongoing retaliatory campaign and bioterrorism
scares.
Telecommunication equipment giant Lucent Technologies
(LU,6.90,f2) said its loss for the fiscal 4Q widened to $0.27
per share, excluding $8 billion in restructuring and one-time
charges, worse than the $0.23 per share First Call consensus
estimate. Including the charges, Lucent's loss widened to $2.59
per share. The company cited the elimination of jobs and some of
its product lines for the charges. Going forward, Lucent
anticipates a sequential fall in revenue in fiscal 1Q before a
rise in fiscal 2Q sales.
Leading U.S. oil company and Dow component Exxon Mobil
(XOM,41,f2) posted 3Q earnings, excluding items, of $0.48 per
share, below the First Call consensus of $0.50 per share on a
9.5% revenue decline amid softening demand and weaker crude
prices. In a similar story, oilfield services company
Schlumberger Ltd. (SLB,48,f2) reported 3Q earnings of $0.34 per
share, $0.01 lower than the Street's mean forecast.
Pharmaceutical titan Bristol-Myers Squibb (BMY,60,f2) posted 3Q
earnings of $0.63 per share, in line with the First call
consensus. Sales of the company's diabetes and blood-clotting
drugs offset declining sales of its flagship cancer and anxiety
medicines.
Insurance and financial services company MetLife (MET,26)
reported that it was eliminating roughly 1,900 jobs in a move to
cut costs amid weakening conditions in the sector. The Snoopy
and Charlie Brown purveyor also reduced its claims estimates
associated with the Sept. 11 attacks to roughly $210 million,
down from the previous forecast of $250 million to $300 million.
The company expects 3Q operating profits of $0.29-$0.31 per
share.
Mobile-phone company AT&T Wireless (AWE,12.94,f2) said 3Q
profits rose to $0.03 per share, well above the $0.02 per share
loss expected by the Street. The company said that it added an
additional 748,000 mobile customers during the quarter and sales
rose 25%, but it plans to leave the fixed wireless business and
take a related pretax 4Q charge.
----------------------------------------------------------------
TREASURY AND ECONOMIC SUMMARY
Bonds were slightly lower as stocks were poised to open higher.
Bonds will likely take direction from the equities market absent
any significant economic data or Fed speak.
----------------------------------------------------------------
WORLD MARKETS
Technology stocks once again led European bourses higher, with
the Bloomberg European 500 Index up 1.99% as of 8:57 a.m. EDT.
Dutch banking company ABN Amro (ABN,14.79,f2) lowered its fiscal
year 2001 earnings guidance in the wake of the terrorist
attacks, while drug giant GlaxoSmithKline PLC (GSK,55) saw its
3Q earnings rise 20%, slightly above expectations. The dollar
continued its upward trend against the euro as traders
anticipate a quicker economic recovery in the U.S. than in other
parts of the world. Adding to the gloomy economic landscape,
Italian business confidence fell to 84 in September from
August's 96, well below expectations. However, September's
French consumer spending data was unexpectedly higher.
Asian markets were higher with Japan's Nikkei-225 finishing up
2.80% led by strength in technology and exporters owing to
continued weakness in the yen. The Japanese currency continued
to slide against the dollar amid a government report that
investors have sought better returns in foreign bonds since the
beginning of the second half of the fiscal year. In earnings
news, Chartered Semiconductor (CHRT,18.70,f1) reported a
better-than-expected 3Q loss of $118.3.million and said it was
close to a bottom in the beleaguered chip industry.
----------------------------------------------------------------
FUTURES WATCH
In the December Globex futures contract as of 8:57 a.m. EDT, the
S&P 500 Index was up 4.5 points (7 points above fair value),
while the Nasdaq 100 Index was up 15.5 points (17 points above
fair value). The December DJIA futures contract was up 28 points
(47 points above fair value) and the December crude oil futures
traded on the NYMEX were up $0.10 at $22.36/barrel.
William Johnson, Market Analyst
================================================================
LOGIN to access your account:
https://investing.schwab.com/trading/start
----------------------------------------------------------------
To unsubscribe or modify your Email Alert customization options,
log in using the link below or copy and paste it into your
browser's address window:
https://investing.schwab.com/trading/start?SANC=EAMyAlerts
----------------------------------------------------------------
Notice: All email sent to or from the Charles Schwab corporate
email system may be retained, monitored and/or reviewed
by Schwab personnel. (0801-11478)
Charles Schwab & Co., Inc. ("Schwab") is a member of the NYSE,
other major U.S. Securities Exchanges, and SIPC. Schwab is a
specialist in various securities on the Pacific, Boston and
Cincinnati Stock Exchanges and is subsidiary of The Charles
Schwab Corporation, which is listed on the NYSE and trades
under the symbol "SCH". Schwab Capital Markets L.P. is a member
of the NASD and SIPC.
Schwab Capital Markets L.P. is also a subsidiary of The Charles
Schwab Corporation and is a market maker in approximately
4,900 securities.
Schwab Center for Investment Research ("SCIR") is part of
Charles Schwab & Co., Inc. The information contained herein is
obtained from sources believed to be reliable, but its accuracy
or completeness is not guaranteed. This report is for
informational purposes only and is not a solicitation, or a
recommendation that any particular investor should purchase or
sell any particular security. Schwab does not assess the
suitability or the potential value of any particular
investment. All expressions of opinions are subject to change
without notice. The Charles Schwab Corporation, Schwab, Schwab
Capital Markets L.P. and its officers, directors, employees,
consultants and/or members of their families may have a position
in, and may from time to time, purchase or sell any of the
mentioned or related securities including derivatives in such
securities. At any given time, Schwab specialists, or Schwab
Capital Markets L.P. market makers, may have an inventory
position, either "long" or "short" in any security mentioned in
this report as a result of their specialist/market making
functions, respectively. Additionally, Schwab or Schwab
Capital Markets L.P. may be on the opposite side of orders
executed on the floor of the Pacific, Boston and/or Cincinnati
Stock Exchanges or over-the-counter market respectively, as
well. Schwab (or persons related thereto) or consultants may
perform or solicit investment banking or other business from
any company mentioned in this report.
(C)2001 Charles Schwab & Co., Inc.
1) Schwab Capital Markets L.P. makes a market in this security.
2) Schwab is a specialist in this security.
3) Schwab has managed or co-managed a public offering in this
security within the last three years.
4) An employee of Schwab is a Director of this company.
5) An analyst covering this stock has an investment position.
Commercial use or redistribution in any form, print or
electronic, is prohibited.
Distribution by Quris, Inc.